ENO2 and leukemia: Co-treatment of human Jurkat T-leukemia cells with various doses of Dx and NSE has revealed the weak antagonistic effect of these compounds only at low doses (0.01 μM, 0.05 μM) for 48 h, revealed by trypan blue exclusion assay and Annexin V/PI double staining.